At Tennyson Advisory, we help early-stage and growth-phase biopharma companies move from scientific promise to strategic execution. Led by Michael Broxson—former CEO, CBO, and longtime pharma executive—our services span fractional C-suite leadership, business development strategy, and transaction advisory. Whether you’re preparing for a licensing deal, raising capital, or refining your go-to-market plan, we bring decades of experience and a hands-on approach to help you make confident, informed decisions. We don’t just advise—we embed, collaborate, and build alongside you.